Clinical trial
Genetic Variants of Annexin A2 and Cryptogenic Stroke
NCT06880107 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Variants of Annexin A2 and Cryptogenic Stroke
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 8, 2025
- Completion date
- April 30, 2027
- Enrollment
- 240 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
annexin a2, fibrinolysis, genetic variants of host, stroke